These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5056014)

  • 1. [Effects of L-dopa on mental functions in parkinsonism].
    Violon A; Peypers J; Rappel M
    Acta Psychiatr Belg; 1972 Mar; 72(2):168-84. PubMed ID: 5056014
    [No Abstract]   [Full Text] [Related]  

  • 2. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF; Chase TN
    Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evolution of intellectual potential and memory in Parkinsonism patients treated with L-dopa].
    Vernet JP; Novi M; Sevilla M; Becle J; Lavagna J; Darcourt G
    Ann Med Psychol (Paris); 1973 Mar; 1(3):413-27. PubMed ID: 4722004
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Rey complex picture test in evaluation of some effects induced by treatment with L-dopa in patients with parkinsonism].
    Megna GF; Puca FM; Micalizzi V; Leggiadro N; Di Rosa AE
    Acta Neurol (Napoli); 1971; 26(4):473-83. PubMed ID: 4943712
    [No Abstract]   [Full Text] [Related]  

  • 5. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa].
    Bergamini L; Bonzanino A; Bignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):10-6. PubMed ID: 5524931
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of L-dopa on individual symptoms of parkinsonism.
    Boshes B; Blonsky ER; Arbit J; Klein K
    Trans Am Neurol Assoc; 1969; 94():229-31. PubMed ID: 5374443
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinsonism, L-dopa, and intelligence.
    Loranger AW; Goodell H; McDowell FH; Lee JE; Sweet RD
    Am J Psychiatry; 1973 Dec; 130(12):1386-9. PubMed ID: 4754685
    [No Abstract]   [Full Text] [Related]  

  • 9. [Figure drawing test in Parkinsonic patients treated with L-dopa].
    Puca FM; Megna GF; Barbieri NF; Di Perri R
    Acta Neurol (Napoli); 1972; 27(4):395-402. PubMed ID: 4563704
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
    Barbieri NF; Megna GF; Micalizzi V; Pigneri MT; Puca FM
    Minerva Med; 1971 Oct; 62(82):4000-3. PubMed ID: 5125063
    [No Abstract]   [Full Text] [Related]  

  • 11. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z; Lackowska H; Maksymowicz B
    Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa in the treatment of Parkinsonism.
    Brezný I; Buranová D; Cernácek J; Trávniková M
    Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in nocturnal sleep in parkinsonism patients treated with L-dopa].
    Bricolo A; Turella G; Mazza CA; Buffatti P; Grosslercher JC
    Sist Nerv; 1970; 22(2):181-90. PubMed ID: 4323416
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
    Knopp W
    Neurology; 1970 Dec; 20(12):Suppl:23-30. PubMed ID: 4921585
    [No Abstract]   [Full Text] [Related]  

  • 16. [L-dopa in the treatment of Parkinsonism].
    Domzal T; Pakszys W
    Wiad Lek; 1972 Aug; 25(15):1391-5. PubMed ID: 5073625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
    Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J
    Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Long term mental changes in levodopa-treated patients.
    Botez MI; Barbeau A
    Lancet; 1973 Nov; 302(7836):1028-9. PubMed ID: 4127251
    [No Abstract]   [Full Text] [Related]  

  • 19. [General intelligence of patients with parkinsonism during L-dopa medication (author's transl)].
    Jacobi P; Fischer PA; Schneider E
    Arch Psychiatr Nervenkr (1970); 1974; 218(2):125-40. PubMed ID: 4817897
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.